Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-15Clinical Trial Update: Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy [NA]
The clinical trial evaluating automatic deformable recontouring on daily MVCT for head and neck cancer adaptive radiotherapy has been withdr…
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer [NA]
A clinical trial evaluating quality of life during radiotherapy for recurrent head and neck cancer has been withdrawn; the study also listed…
-
CLINICAL_TRIALS withdrawal · 2025-12-02Clinical Trial Update: Implementation of a Standardized Tracheostomy Education Discharge Protocol [NA]
A clinical trial evaluating a standardized tracheostomy education discharge protocol for head and neck cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-10-28Clinical Trial Update: Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery [NA]
The clinical trial evaluating an online peri-operative education program for patients undergoing major head and neck surgery has been withdr…
-
CLINICAL_TRIALS withdrawal · 2025-10-01Clinical Trial Update: Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve [NA]
A clinical trial investigating intraoperative identification and stimulation of the glossopharyngeal nerve (NCT05754216) sponsored by Vander…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-09-29Clinical Trial Update: Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course
A clinical trial evaluating sleep quality in patients with head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer [NA]
A trial evaluating temsirolimus (Torisel) added to standard chemotherapy with radiation for advanced head and neck cancer has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia [NA]
Trial assessing MRI sialography to spare parotid ducts for reduced xerostomia in oropharyngeal/head and neck cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-17Clinical Trial Update: Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study [NA]
The SupCare study evaluating simultaneous care in recurrent and/or metastatic head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-04Clinical Trial Update: Defining Musical Toxicity and Its Effect on Patient Well-being
A Mayo Clinic-sponsored clinical trial titled 'Defining Musical Toxicity and Its Effect on Patient Well-being' has been withdrawn from the r…
-
CLINICAL_TRIALS withdrawal · 2025-03-28Clinical Trial Update: Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab [Phase 3]
A Phase 3 study evaluating radiation therapy and chemotherapy with or without Nimotuzumab for head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-07Clinical Trial Update: Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery
The clinical trial evaluating pre-operative virtual visits for head and neck cancer surgery was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-04Clinical Trial Update: Mood Disorders in Head and Neck Cancer Patients [Phase 4]
Phase 4 clinical trial investigating mood disorders in head and neck cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Functional and Molecular Characterization of Treatment Response in Tumors in the Oral Cavity Using Optical Spectroscopy [NA]
A clinical trial investigating optical spectroscopy to characterize treatment response in oral cavity/head and neck cancer has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2024-09-23Clinical Trial Update: Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study) [NA]
The I-PAP study investigating increasing physical activity in patients with head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. [Phase 3]
Phase 3 trial evaluating gabapentin to reduce the need for strong opioid use in head and neck cancer patients has been withdrawn. The study …
-
CLINICAL_TRIALS withdrawal · 2024-05-06Clinical Trial Update: StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients [NA]
A clinical trial evaluating StrataXRT for prevention and treatment of radiation dermatitis in breast cancer or head and neck cancer patients…
-
CLINICAL_TRIALS withdrawal · 2022-02-08Clinical Trial Update: Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck [Phase 2, Phase 3]
A clinical trial investigating enoblituzumab with MGA012 or MGD013 in squamous cell carcinoma of the head and neck has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-07-09Clinical Trial Update: Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery [Phase 4]
A Phase 4 trial evaluating pre-operative pregabalin for postoperative pain in head and neck cancer surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-12-20Clinical Trial Update: Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) [Phase 3]
Phase 3 trial CheckMate 9NA/ECHO-310 evaluating nivolumab plus epacadostat with chemotherapy versus EXTREME in squamous cell carcinoma of th…
-
CLINICAL_TRIALS withdrawal · 2019-04-18Clinical Trial Update: An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck [Phase 3]
Phase 3 trial evaluating nivolumab with BMS-986205 versus EXTREME in first-line recurrent/metastatic squamous cell carcinoma of the head and…
-
CLINICAL_TRIALS withdrawal · 2019-01-30Clinical Trial Update: Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer
A clinical trial investigating biomarkers in tissue samples from patients who underwent neck dissection for oral cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation [Phase 2, Phase 3]
A Phase 2/3 trial comparing PET imaging tracers F-18 FLT and F-18 FDG for treatment evaluation in head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-09Clinical Trial Update: Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery [Phase 2]
This ClinicalTrials.gov entry reports that the Phase 2 trial evaluating cetuximab with chemotherapy and radiation for newly diagnosed stage …
-
CLINICAL_TRIALS withdrawal · 2017-08-08Clinical Trial Update: CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy [Phase 3]
Phase 3 trial evaluating CD2 lozenges to prevent acute oral mucositis in head and neck cancer patients undergoing radiotherapy and chemother…